Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37151112> ?p ?o ?g. }

Showing items 1 to 100 of ±137 with 100 items per page.

Q37151112 description "2016 թվականի հուլիսի 12-ին հրատարակված գիտական հոդված" @default.
Q37151112 description "article científic" @default.
Q37151112 description "article scientifique" @default.
Q37151112 description "articolo scientifico" @default.
Q37151112 description "artigo científico" @default.
Q37151112 description "artículu científicu espublizáu en 2016" @default.
Q37151112 description "bilimsel makale" @default.
Q37151112 description "scientific article published on 12 July 2016" @default.
Q37151112 description "vedecký článok" @default.
Q37151112 description "vetenskaplig artikel" @default.
Q37151112 description "videnskabelig artikel" @default.
Q37151112 description "vědecký článek" @default.
Q37151112 description "wetenschappelijk artikel" @default.
Q37151112 description "wissenschaftlicher Artikel" @default.
Q37151112 description "наукова стаття, опублікована в липні 2016" @default.
Q37151112 description "научни чланак" @default.
Q37151112 description "مقالة علمية نشرت في 12 يوليو 2016" @default.
Q37151112 name "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 name "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 name "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 type Item @default.
Q37151112 label "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 label "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 label "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 prefLabel "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 prefLabel "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 prefLabel "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma." @default.
Q37151112 P1433 Q37151112-3A787D58-8FC0-4B61-BB96-8739249D3631 @default.
Q37151112 P1476 Q37151112-DBE85DB4-E6DE-420D-84B4-140009C08166 @default.
Q37151112 P2093 Q37151112-0C7EF83D-BD1C-4A84-8118-5F5B8FAF76FD @default.
Q37151112 P2093 Q37151112-13E630D7-AB56-432E-BAB7-0EBC37006ACD @default.
Q37151112 P2093 Q37151112-243CB646-FFCE-4FB2-87BB-58443C46FC46 @default.
Q37151112 P2093 Q37151112-51E7A15E-FBFC-4904-B1E8-504078F42DDF @default.
Q37151112 P2093 Q37151112-5633D615-2493-462F-9AF2-981660DAB2A5 @default.
Q37151112 P2093 Q37151112-701FA195-C1B8-4D91-B6C4-9631899DFB6A @default.
Q37151112 P2093 Q37151112-A925072A-7A3D-4B8B-99A0-E5F8B3BB0E5D @default.
Q37151112 P2093 Q37151112-CA37E64D-1404-40A3-8E10-EC07393CBD85 @default.
Q37151112 P2093 Q37151112-EB0F7EB7-2642-4EFA-8EA0-85665633F2C9 @default.
Q37151112 P2093 Q37151112-F97C0E4A-412F-43AB-B009-83EF03108D69 @default.
Q37151112 P275 Q37151112-ad7e98dd-000e-44ee-9462-9e5f4d2273ff @default.
Q37151112 P2860 Q37151112-0A6AA748-ECDA-44F0-80C2-9295477FA6EF @default.
Q37151112 P2860 Q37151112-0BCC2D78-A2A7-4035-95AA-5FB4E8E2D12C @default.
Q37151112 P2860 Q37151112-104A7D7D-0518-464C-A39B-F1DBE3138FC4 @default.
Q37151112 P2860 Q37151112-164D9BBD-995C-467C-BC23-8376A67EB43E @default.
Q37151112 P2860 Q37151112-1B05CA1E-F454-4983-A07C-E3041081ABCE @default.
Q37151112 P2860 Q37151112-3519E0B3-4956-4C4A-A691-BD59AACBB23C @default.
Q37151112 P2860 Q37151112-3A493109-AEE0-476E-B969-DD996C7C46CF @default.
Q37151112 P2860 Q37151112-40ECF0DA-062D-40F4-ACA4-3E149573A095 @default.
Q37151112 P2860 Q37151112-410B27B3-32E1-41F4-AED2-7F8FD5AEEF0A @default.
Q37151112 P2860 Q37151112-50446F06-EA5A-486A-B75B-09A524BC639E @default.
Q37151112 P2860 Q37151112-61467A43-49FE-451C-8385-408313FB7AB6 @default.
Q37151112 P2860 Q37151112-73E1DC31-41E2-4096-ACE1-17965FA4BF00 @default.
Q37151112 P2860 Q37151112-78977FDE-435F-4C7E-A598-AA9A5839B37B @default.
Q37151112 P2860 Q37151112-8B8B954B-869C-4985-A0C6-1AC1D0F0B2B3 @default.
Q37151112 P2860 Q37151112-9D31FEC6-B697-4374-993E-45D9CAC3929F @default.
Q37151112 P2860 Q37151112-9F79A308-D772-4FC4-B074-3E9893033690 @default.
Q37151112 P2860 Q37151112-A86D7E35-B908-45C7-ACDA-F2B503EE5677 @default.
Q37151112 P2860 Q37151112-AD463296-56DF-4093-A808-A5064ED83199 @default.
Q37151112 P2860 Q37151112-AD55C467-EFD0-4C9B-A9F6-824E7976491E @default.
Q37151112 P2860 Q37151112-C2FE865E-5867-4333-9C9A-9C1139545F9F @default.
Q37151112 P2860 Q37151112-DB8D429C-2C26-456A-A9DB-07BD146EB00F @default.
Q37151112 P2860 Q37151112-DD1E1BAE-113F-492E-AEBF-038A226C19C3 @default.
Q37151112 P2860 Q37151112-E6AFEFEB-C709-4021-939F-F8BB48A3E6DE @default.
Q37151112 P2860 Q37151112-F48AEAB5-8A81-42F1-839C-DD9B429498BD @default.
Q37151112 P2860 Q37151112-F51E5FEB-0E4F-4E3B-9638-026CDACAE15C @default.
Q37151112 P2888 Q37151112-9D44DBD3-CBFF-4EED-9DE7-1D39BAC757F3 @default.
Q37151112 P304 Q37151112-9447D0B3-38AB-45F6-ACEA-C38A44D5F564 @default.
Q37151112 P31 Q37151112-23DC9D95-5E7B-48B7-B003-EBB96AAF2A06 @default.
Q37151112 P356 Q37151112-8A43F8E8-3D89-4650-909A-759B8CEC1224 @default.
Q37151112 P407 Q37151112-69946E60-9E9A-4A90-996B-4B3753DC6352 @default.
Q37151112 P433 Q37151112-A221167F-EE05-4A0C-B9C8-75E59F81AD9B @default.
Q37151112 P478 Q37151112-FF79F9E9-29E7-4DC1-9D7C-DFDD07F0839D @default.
Q37151112 P50 Q37151112-4A15C12E-CD75-4D3D-A0CF-8828A4EEB03A @default.
Q37151112 P50 Q37151112-AD3FAC0C-C3C0-4F07-96F2-FDE1EBC4C2F9 @default.
Q37151112 P577 Q37151112-593F948C-217B-4062-8D35-E56D9F5008B2 @default.
Q37151112 P6216 Q37151112-f5d73970-960d-4182-961f-2b3174a1f402 @default.
Q37151112 P698 Q37151112-41305A2C-29C1-4050-9CA1-358CBBAB2ABA @default.
Q37151112 P921 Q37151112-06C82F0D-CEF3-435F-AF78-A37C040D5D4B @default.
Q37151112 P921 Q37151112-1EFB7B52-C249-4DE5-BD79-3676672D308E @default.
Q37151112 P921 Q37151112-E29FD9A8-57C2-485D-B217-A0E65A0E8027 @default.
Q37151112 P932 Q37151112-D9B7094D-0A46-46E5-9FFC-EC627C8C3488 @default.
Q37151112 P356 BJC.2016.209 @default.
Q37151112 P698 27404453 @default.
Q37151112 P1433 Q326309 @default.
Q37151112 P1476 "Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma" @default.
Q37151112 P2093 "Clara Fugazza" @default.
Q37151112 P2093 "Claudio Doglioni" @default.
Q37151112 P2093 "Domenica Ceraulo" @default.
Q37151112 P2093 "Gianpaolo Balzano" @default.
Q37151112 P2093 "Gino Pepe" @default.
Q37151112 P2093 "Massimo Falconi" @default.
Q37151112 P2093 "Michele Reni" @default.
Q37151112 P2093 "Paolo Passoni" @default.
Q37151112 P2093 "Roberto Nicoletti" @default.
Q37151112 P2093 "Silvia Zanon" @default.
Q37151112 P275 Q42553662 @default.
Q37151112 P2860 Q29616728 @default.
Q37151112 P2860 Q33366562 @default.
Q37151112 P2860 Q33385281 @default.
Q37151112 P2860 Q33395577 @default.